74 related articles for article (PubMed ID: 9190958)
21. HIV-1-specific production of IFN-gamma and modulation by recombinant IL-2 during early HIV-1 infection.
Rinaldo C; Piazza P; Wang YZ; Armstrong J; Gupta P; Ho M; Petteway S; Reed D; Lyter D; Kingsley L
J Immunol; 1988 May; 140(10):3389-93. PubMed ID: 2452186
[TBL] [Abstract][Full Text] [Related]
22. Interferon-gamma and interleukin-10 production among HIV-1-infected and uninfected infants of HIV-1-infected mothers.
Kuhn L; Coutsoudis A; Moodley D; Mngqundaniso N; Trabattoni D; Shearer GM; Clerici M; Coovadia HM
Pediatr Res; 2001 Sep; 50(3):412-6. PubMed ID: 11518830
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity of cytokine functions in HIV infection.
Kundu SK; Merigan TC
Immunology; 1997 Jun; 91(2):234-8. PubMed ID: 9227322
[TBL] [Abstract][Full Text] [Related]
24. High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection.
McFarland EJ; Harding PA; Luckey D; Conway B; Young RK; Kuritzkes DR
J Infect Dis; 1994 Oct; 170(4):766-74. PubMed ID: 7930716
[TBL] [Abstract][Full Text] [Related]
25. Increased T-helper-type 2 cytokine production in chronic HIV infection is due to interleukin (IL)-13 rather than IL-4.
Zou W; Dulioust A; Fior R; Durand-Gasselin I; Boue F; Galanaud P; Emilie D
AIDS; 1997 Mar; 11(4):533-4. PubMed ID: 9084802
[No Abstract] [Full Text] [Related]
26. Cytotoxic T lymphocyte lines specific for human immunodeficiency virus type 1 Gag and reverse transcriptase derived from a vertically infected child.
McFarland EJ; Curiel TJ; Schoen DJ; Rosandich ME; Schooley RT; Kuritzkes DR
J Infect Dis; 1993 Mar; 167(3):719-23. PubMed ID: 7680062
[TBL] [Abstract][Full Text] [Related]
27. Type 1 and type 2 cytokine profiles in children exposed to or infected with vertically transmitted human immunodeficiency virus.
Lee BN; Lu JG; Kline MW; Paul M; Doyle M; Kozinetz C; Shearer WT; Reuben JM
Clin Diagn Lab Immunol; 1996 Sep; 3(5):493-9. PubMed ID: 8877124
[TBL] [Abstract][Full Text] [Related]
28. Early HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants.
Pikora CA; Sullivan JL; Panicali D; Luzuriaga K
J Exp Med; 1997 Apr; 185(7):1153-61. PubMed ID: 9104802
[TBL] [Abstract][Full Text] [Related]
29. [Role of cytokines and chemokines in the non-progression of HIV infection in vertically infected children].
Resino S; Bellón JM; Jiménez JL; Gurbindo MD; Muñoz-Fernández MA
Med Clin (Barc); 2000 May; 114(17):641-6. PubMed ID: 10900602
[TBL] [Abstract][Full Text] [Related]
30. In vitro HIV-specific CTL activity from HIV-seropositive individuals is augmented by interleukin-12 (IL-12).
Young JM; Ffrench RA; Clarkson JD; Stewart GJ; Liang T; Tideman RL; Packham D; Fulcher DA; Benson EM
AIDS Res Hum Retroviruses; 2001 Feb; 17(3):233-42. PubMed ID: 11177406
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic T lymphocytes generation capacity in early life with particular reference to HIV.
Rivière Y; Buseyne F
Vaccine; 1998; 16(14-15):1420-2. PubMed ID: 9711782
[TBL] [Abstract][Full Text] [Related]
32. Early HIV-specific cytotoxic T lymphocytes and disease progression in children born to HIV-infected mothers.
Buseyne F; Burgard M; Teglas JP; Bui E; Rouzioux C; Mayaux MJ; Blanche S; Rivière Y
AIDS Res Hum Retroviruses; 1998 Nov; 14(16):1435-44. PubMed ID: 9824321
[TBL] [Abstract][Full Text] [Related]
33. Cytokines and impaired CD8+ CTL activity among elderly persons and the enhancing effect of IL-12.
Mbawuike IN; Acuna CL; Walz KC; Atmar RL; Greenberg SB; Couch RB
Mech Ageing Dev; 1997 Mar; 94(1-3):25-39. PubMed ID: 9147358
[TBL] [Abstract][Full Text] [Related]
34. In vitro measurement of cytotoxic T cell activity does not predict clinical progression in paediatric HIV disease--two case studies.
Froebel KS; Mok JY; Aldhous MC; Armitage MP; Arnott M; Reynolds LM; Peutherer JF; Burns SM
Clin Exp Immunol; 1997 Oct; 110(1):15-21. PubMed ID: 9353143
[TBL] [Abstract][Full Text] [Related]
35. Altered signaling lymphocytic activation molecule (SLAM) expression in HIV infection and redirection of HIV-specific responses via SLAM triggering.
Meroni L; Fusi ML; Varchetta S; Biasin M; Rusconi S; Villa ML; De Vries JE; Aversa G; Galli M; Clerici M
Clin Immunol; 1999 Sep; 92(3):276-84. PubMed ID: 10479532
[TBL] [Abstract][Full Text] [Related]
36. Low maternal viral loads and reduced granulocyte-macrophage colony-stimulating factor levels characterize exposed, uninfected infants who develop protective human immunodeficiency virus type 1-specific responses.
Schramm DB; Meddows-Taylor S; Gray GE; Kuhn L; Tiemessen CT
Clin Vaccine Immunol; 2007 Apr; 14(4):348-54. PubMed ID: 17301218
[TBL] [Abstract][Full Text] [Related]
37. Lack of CD28 expression on HIV-specific cytotoxic T lymphocytes is associated with disease progression.
Gamberg J; Pardoe I; Bowmer MI; Howley C; Grant M
Immunol Cell Biol; 2004 Feb; 82(1):38-46. PubMed ID: 14984593
[TBL] [Abstract][Full Text] [Related]
38. Immunologic characterization of children vertically infected with human immunodeficiency virus, with slow or rapid disease progression.
Viganó A; Principi N; Villa ML; Riva C; Crupi L; Trabattoni D; Shearer GM; Clerici M
J Pediatr; 1995 Mar; 126(3):368-74. PubMed ID: 7869194
[TBL] [Abstract][Full Text] [Related]
39. Disruption in cytokine and chemokine production by T-cells in vertically HIV-1-infected children.
Resino S; Bellón JM; Gurbindo D; Muñoz-Fernández MA
Acta Paediatr; 2001 Sep; 90(9):989-97. PubMed ID: 11683211
[TBL] [Abstract][Full Text] [Related]
40. The avidity of allospecific cytotoxic T lymphocytes (CTL) determines their cytokine production profile.
Van Emmerik NE; Daane CR; Knoop CJ; Hesse C; Vaessen LM; Balk AH; Mochtar B; Claas FH; Weimar W
Clin Exp Immunol; 1997 Dec; 110(3):447-53. PubMed ID: 9409650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
